Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
QuintilesIMS
Accenture
Argus Health
Citi
Johnson and Johnson
Mallinckrodt
Fuji
Julphar
Chinese Patent Office

Generated: August 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Patent Claims: 1. A compound of the formula ##STR58## where Q is selected from the group consisting of ##STR59## R.sup.1 is selected from the group consisting of 4-, 3-, or 2-pyridyl, pyrimidyl, pyrazinyl, and fluoro-4-pyridyl;

R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, --NO.sub.2, --OH, R.sup.4, --OR.sup.4, --CO.sub.2 R.sup.4, --COR.sup.4, --CONH.sub.2, --CONHR.sup.4, --CONR.sup.4 R.sup.4', --S(O).sub.m --R.sup.4, --NH.sub.2, --CF.sub.3, --NHR.sup.4, and --NR.sup.4 R.sup.4' ;

R.sup.4 and R.sup.4' are independently selected from the group consisting of H, alkyl of 1 to 4 carbons, --CH.sub.2 Phe-W and --Phe-W;

Phe is a phenyl group;

R.sup.5 is selected from the group consisting of --(CH.sub.2).sub.n --Y and --OCOR.sup.4 ;

Y is selected from the group consisting of H, --OH, --NH.sub.2, --NHR.sup.4, --NR.sup.4 R.sup.4', --NHCO.sub.2 R.sup.4, --NHS(O).sub.2 R.sup.4, F, Cl, Br, --OR.sup.4, --S(O).sub.m R.sup.4, --CO.sub.2 H, --CO.sub.2 R.sup.4, --CN, --CONR.sup.4 R.sup.4' --CONHR.sup.4, --CONH.sub.2, --COR.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, --OCOR.sup.4, -Phe, -Phe-W, --C.tbd.CCO.sub.2 R.sup.4, --CH.dbd.CHR.sub.4, and --C.tbd.C R.sup.4 ;

W is selected from the group consisting of F, Cl, Br, --NO.sub.2, --NH.sub.2, and --CN;

m is 0, 1 or 2;

n is 1 to 7;

and hydrates and physiologically suitable salts thereof.

2. A compound of claim 1 where R.sup.1 is selected from the group consisting of 4-pyridyl, 4-pyrimidyl, and 2-fluoro-4-pyridyl.

3. A compound of claim 1 where R.sub.5 is --(CH.sub.2).sub.n --Y.

4. A compound of claim 3 where Y is selected from the group consisting of --CO.sub.2 R.sup.4, --CN, --CONHR.sup.4, --NHCOR.sup.4, --NHCO.sub.2 R.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, and --OCOR.sup.4.

5. A compound of claim 1 where R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, OH, --R.sup.4, --OR.sup.4, --CO.sub.2 R.sup.4, --COR.sup.4, --CONH.sub.2, --CONHR.sup.4, --CONR.sup.4 R.sup.4' and --S(O)m.sup.R.sup.4, and R.sup.4 and R.sup.4' are independently selected from the group consisting of alkyl of 1 to 4 carbon atoms.

6. A compound of claim 2 where R.sub.5 is --(CH.sub.2).sub.n --Y and n is 1 to 4.

7. A compound of claim 6 where Y is selected from the group consisting of --CO.sub.2 R.sup.4, --CN, --CONHR.sup.4, --NHCOR.sup.4, --NHCO.sub.2 R.sup.4, --CH.dbd.CHCO.sub.2 R.sup.4, and --OCOR.sup.4.

8. A compound of claim 6 where R.sup.2 and R.sup.3 are independently selected from the group consisting of H, F, Cl, Br, --CH.sub.3 and --CO.sub.2 R.sup.4, and R.sup.4 is selected from the group consisting of alkyl of 1 to 4 carbons.

9. The compound of claim 1 which is 4-[9-(4-Pyridinylmethyl)-9H-fluoren-9-yl]-2-butenoic Acid Ethyl Ester Dihydrochloride.

10. The compound of claim 1 which is 9-(4-Pyridinylmethyl)-9H-fluoren-9-acetic Acid Ethyl Ester Hydrochloride.

11. The compound of claim 1 which is 9-(4-Pyridinylmethyl)-9H-fluoren-9-butanamide Hemihydrate.

12. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 1.

13. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 2.

14. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 3.

15. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 4.

16. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 5.

17. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 6.

18. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 7.

19. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 8.

20. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 9.

21. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 10.

22. A pharmaceutical composition comprising a suitable pharmaceutical carrier and a therapeutically effective amount of a compound of claim 11.

23. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 1.

24. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 2.

25. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 3.

26. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 4.

27. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 5.

28. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 6.

29. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 7.

30. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 8.

31. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 9.

32. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 10.

33. A method for the treatment of cognitive or neurological dysfunction in a mammal comprising administering to the mammal a therapeutically effective amount of a compound of claim 11.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
US Army
McKesson
Express Scripts
US Department of Justice
UBS
Mallinckrodt
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot